XT-1061

N/A

Report date: 2026/02/11 20:01:36
NME

Base Information

Drug NameXT-1061
Drug Alias NameXTYW-001XTYW001XT-1061XT1061
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein inhibitors
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXi'an Xintong Pharmaceutical Research Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesXi'an Xintong Pharmaceutical Research Co LtdXi'An Gelan Xintong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A